## Abstract The in vitro antiviral activity of dermaseptins (S1–S5) against herpes simplex virus type 1 (HSV1) was investigated. These peptides were incubated with the virus and its target cells under various conditions, and their effects were examined by the cytopathic effect inhibition assay or b
Preliminary characterization of a mutant of herpes simplex virus type 1 selected for acycloguanosine resistance in vitro
✍ Scribed by Dr. Giorgio Palú; Wilma P. Summers; Sebastiano Valisena; Mauro Tognon
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 708 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
In this paper we report on the preliminary characterization of a mutant of herpes simplex virus type. 1 (HSV-1) selected for acycloguanosine (acyclovir, ACV) resistance in vitro. The ACV' virus was examined for a series of parameters that include chemosensitivity assay, thymidine kinase (TK) activity, in vitro and in vivo growth, and mutation mapping. The data obtained indicate that a mutated TK gene is responsible for the ACV' phenotype. A distinctive feature of this mutant is the high level of resistance exhibited to ACV (100 pM) and the concomitant presence of a functional TK activity. Such a property makes this virus useful as a model for the study of viral resistance to nucleoside-type analogues in HSV.
📜 SIMILAR VOLUMES
This study was carried out to determine the prevalence of antibodies to herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) in selected German populations, such as blood donors, hospital patients, and human immunodeficiency virus (HIV)-seropositive individuals. Serum samples collected between 1996 an
Recurrent acyclovir (ACV)-resistant (ACV-r) herpes simplex virus type 1 (HSV-1) infections occurred in a patient with Wiskott-Aldrich syndrome, an X-linked recessive immunodeficiency syndrome composed of three clinical characteristics of immunodeficiency, thrombocytopenia, and an eczematous dermatit
Adult BALB/c mice, genetically resistant to HSV-1 i.p. infection, were inoculated intraperitoneally with 1000 PFU of HSV-1 and treated by the same route with four consecutive doses of Melia azedarach L. aqueous green leaves extract (MA) each containing 80 antiviral units against HSV-1 replication in